Pfizer’s Mylotarg ... after the FDA reapproved it in the aggressive blood cancer, acute myeloid leukaemia. The world’s first approved antibody-drug conjugate, where a targeted antibody ...

the US Food and Drug Administration (FDA) approved fidanacogene elaparvovec (Beqvez), only the second gene therapy product for hemophilia B. Just a few months later, the Pfizer treatment ...

April 21, 2025 – The FDA just approved the popular drug Dupixent ... said in a news release from Sanofi, the drug's maker. Developed by Sanofi and Regeneron and first approved in 2017 ...